Axogen, Inc. Common Stock AXGN
Analyst Ratings
- Consensus
- Buy — 9 Buy · 0 Hold · 0 Sell (9 analysts)
- Avg. Price Target
- $46.00 (+5.1% upside)
Key Stats
- Today's Range
- $41.55 – $44.00
- 50-Day Range
- $38.23 – $52.91
- 52-Week Range
- $13.64 – $52.91
- Volume
- 1.67 million shs
- Average Volume
- 1.05 million shs
- Market Cap
- $2.27 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 8.84
- Price / Sales
- 9.02
Short Interest
- Short Interest
- 2.05%
- Days to Cover
- 4.94
Financials (TTM)
- Revenue
- $251.17 million
- Net Income
- $-33,548,000
- Net Margin
- -13.36%
- Return on Equity
- -13.09%
- Debt-to-Equity
- —
About Axogen, Inc. Common Stock
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
Related Stocks
Compare head-to-head: AXGN vs MDT·AXGN vs BLFS·AXGN vs CNMD·AXGN vs FOCL
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.